NEOMEDLIGHT SAS of Villeurbanne at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

NEOMEDLIGHT SAS

88-90 rue Frédéric Fays, 69100 Villeurbanne
France

This company is co-exhibitor of
Business France SA

Hall map

MEDICA 2019 hall map (Hall 15): stand B10

Fairground map

MEDICA 2019 fairground map: Hall 15

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.02  Imaging supplies
  • 01.02.03  X-ray devices and accessories

X-ray devices and accessories

Our products

Product category: X-ray devices and accessories

BILICOCOON® JAUNDICE THERAPY

BiliCocoon® is a medical device by NeoMedLight (certified ISO13485). It is targeted at treating neonatal jaundice without compromising the relationship between the mother and the newborn.

For maximum effectiveness, it offers an intensive and homogeneous irradiance (35 microW/cm²/nm), and a large coverage of body surface area (1200 cm²), It is emitting light in the absorption spectrum of bilirubin: from 430 to 490 nm , facilitating the reduction of bilirubin concentration in the blood.

Besides, it allows
  • a safe and controlled therapy,
  • cocooning including breastfeeding,
  • flexibility in usage in different settings both at hospital and at home,
  • a potential savings through optimized workflow and lighter burden on staff.

More Less

About us

Company details

WHO WE ARE

NeoMedLight develops innovative medical devices designed for phototherapy. The company is the owner of a unique and proprietary technology: the emission of light through woven optic fibers, the Fabric of Light (Lightex®). This technology was originally developed by Brochier Technologies (www.brochiertechnologies.com) with which NeoMedLight shares the overall ownership. NeoMedLight has the exclusivity in healthcare.

The company has initially conceived and developed a fiber-optic phototherapy device to treat neonatal jaundice; Further therapeutic indications that would benefit from the Fabric of Light may include mucositis, dermatitis, wound healing/tissue regeneration, as well as pain management.

The objective of NeoMedLight® is to bring the innovation to all therapeutic fields in which it will benefit patients and healthcare providers.

NeoMedLight is certified ISO 13485

More Less